Arnav Mehta is a practicing gastrointestinal oncologist and venture partner at The Column Group who runs a computational and experimental lab at the Broad Institute focused on pancreatic cancer plasticity, giving him direct clinical and research experience while investing in therapeutics companies. He has founded multiple companies including Monimoi Therapeutics and served as a founding team member at several immunology/oncology startups during his role as Entrepreneur-in-Residence at Third Rock Ventures, with academic training spanning mathematics, chemistry, medicine, and immunology under mentors including Nobel laureate David Baltimore.